Authors: Klijn, JGM Beex, LVAM Mauriac, L van Zijl, JA Veyret, C Wildiers, J Jassem, J Piccart, M Burghouts, J Becquart, D Seynaeve, C Mignolet, F Duchateau, L

Citation: Jgm. Klijn et al., Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study, J NAT CANC, 92(11), 2000, pp. 903-911

Authors: Blamey, R Blichert-Toft, M Cataliotti, L Costa, A Greco, M Holland, R Kaufmann, M Perry, N Ponti, A Redmond, K Sainsbury, R van de Velde, C Christiaens, M Jassem, J Julien, JP Paridaens, R Rutgers, E van Limbergen, EF Van den Bogaert, W Vergote, I Wildiers, J

Citation: R. Blamey et al., The requirements of a specialist breast unit, EUR J CANC, 36(18), 2000, pp. 2288-2293

Authors: Paridaens, R Biganzoli, L Bruning, P Klijn, JGM Gamucci, T Houston, S Coleman, R Schachter, J Van Vreckem, A Sylvester, R Awada, A Wildiers, J Piccart, M

Citation: R. Paridaens et al., Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European organization for research and treatment of cancer randomized study with cross-over, J CL ONCOL, 18(4), 2000, pp. 724-733

Authors: Vinholes, J Coleman, R Lacombe, D Rose, C Tubiana-Hulin, M Bastit, P Wildiers, J Michel, J Leonard, R Nortier, J Mignolet, F Ford, J

Citation: J. Vinholes et al., Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion, BR J CANC, 80(1-2), 1999, pp. 221-228